By HCO Staff
NEW YORK CITY—In a move that has the potential to change the future of surgery, Mount Sinai Health System announced in late August the launch of the Comprehensive Center for Surgical Innovation (CCSI). This bold new initiative is supported by an $11.6 million grant from Mayor Eric Adams and New York City Economic Development Corporation (NYCEDC) and expands upon the activities of Mount Sinai Biodesign, the Health System’s device incubator.
Mayor Adams made the announcement that Mount Sinai Health System along with The City College of New York (CCNY) would each receive multimillion-dollar investments to support the construction of new facilities.
“With these awards, our administration is making critical investments in the health and prosperity of New Yorkers,” said Mayor Adams. “Life sciences are central to our city’s public health and economic recovery, and we will continue to marshal the resources necessary to grow this industry, create new economic opportunities for New Yorkers, and keep our city moving forward.”
The Center will be located in a new state-of-the-art facility at 432 West 58th Street in Midtown Manhattan, steps from the Mount Sinai West hospital campus. The CCSI will facilitate and accelerate the development and commercialization of innovative technologies and instrumentation that will enhance the safety, quality, and efficiency of surgical procedures, resulting in improved outcomes among patients in New York City and globally. It will propel innovation in surgical technology development by training a diverse generation of researchers, engineers, and physicians, resulting in solutions that reflect a wider range of perspectives, cultures, and backgrounds and thus have wide-reaching benefits.
This investment from NYCEDC is intended to amplify the efforts of Mount Sinai BioDesign, which has attracted innovative startup companies and venture capital to New York City and has inspired new ventures generating commercial licensing agreements and millions in funding. The new CCSI will build upon success in scaling innovative discoveries, nurturing collaborative partnerships with industry leaders, and supporting a pipeline of young entrepreneurs who launch startup companies that bring new ideas to the market and into surgical arenas around the world. These initiatives will not only improve the delivery of care but also generate new jobs, diversify the pool of life sciences talent, and serve as a major driver of economic development for New York City.